Techh.info/biomedtechnology hourly

Cancer

headlines texts
05.08.2019
23:13 CancerNetwork.comWhat Characterizes Breast Cancer in Adolescent and Young Adult Patients?

Researchers looked at the characteristics of breast cancer found in patients under 40-years-old.

Скрыть анонс
22:39 CancerNetwork.comWhere Does T-DM1 Fit In First-Line Treatment for HER2-Positive Breast Cancer?

A phase III trial tested trastuzumab emtansine (T-DM1) with or without pertuzumab in patients with HER2-positive metastatic breast cancer.

Скрыть анонс
21:25 ScienceDaily.comShrinking brain tumors and opening the door for targeted cancer therapies

A new drug, known as IP1867B, could be used for future treatments of brain tumors. The research team showed that IP1867B worked with existing cancer treatments boosting their effectiveness and, in some cases, restored sensitivity to some treatments.

Скрыть анонс
21:25 ScienceDaily.comRaman spectroscopy poised to make thyroid cancer diagnosis less invasive

Researchers have demonstrated that an optical technique known as Raman spectroscopy can be used to differentiate between benign and cancerous thyroid cells. The new study shows Raman spectroscopy's potential as a tool to improve the diagnosis of thyroid cancer, which is the ninth most common cancer with more than 50,000 new cases diagnosed in the United States each year.

Скрыть анонс
20:36 Drugs.comAHA News: Common Prostate Cancer Treatment May Increase Risk of Fatal Heart Condition

MONDAY, Aug. 5, 2019 (American Heart Association News) -- Many men with prostate cancer rely on common testosterone-blocking drugs as a part of their treatment. But those so-called antiandrogens also might put them at risk for a deadly heart...

Скрыть анонс
20:12 Phys.orgRaman spectroscopy poised to make thyroid cancer diagnosis less invasive

Researchers have demonstrated that an optical technique known as Raman spectroscopy can be used to differentiate between benign and cancerous thyroid cells. The new study shows Raman spectroscopy's potential as a tool to improve the diagnosis of thyroid cancer, which is the ninth most common cancer with more than 50,000 new cases diagnosed in the United States each year.

Скрыть анонс
19:00 ScientificAmerican.ComCancer Research in a Nutshell

A website called OncoBites offers short, easy-to-understand reports on what’s new in the field -- Read more on ScientificAmerican.com

Скрыть анонс
18:40 Medscape.ComCancer Survival Linked to Antidepressant Adherence

A study of more than 42,000 patients provides the first data showing that patients with cancer who took their antidepressants as prescribed survived longer. Experts, however, remain unconvinced.

Скрыть анонс
17:34 SeekingAlpha.comProgenics completes enrollment in late-stage study of prostate cancer imaging agent

Скрыть анонс
17:09 Phys.orgMore than half a million Americans exposed to toxic air pollution face cancer risks above EPA guidelines

Neighbors used to barely notice the drab, low-slung industrial building across the river from downtown.

Скрыть анонс
16:09 News-Medical.NetMSI detection in blood samples can guide treatment planning for patients with advanced cancer

Incorporation of pan-cancer microsatellite instability (MSI) detection into the 74-gene panel Guardant360 liquid biopsy assay showed high concordance with matched tissue samples in nearly 1,000 patients.

Скрыть анонс
15:27 Yahoo ScienceAfter 3-year cancer battle, 5-year-old opens lemonade stand to give back

After battling leukemia for over three years, 5-year-old Gabe Rodriguez is now a cancer survivor and ready to help other kids who are battling the disease -- one cup of lemonade at a time. Gabe was 22-months-old when he was diagnosed with acute lymphoblastic leukemia, a cancer of the blood and bone marrow that affects white blood cells. "The doctor told us, 'This is the best situation of a s------ situation,'" said Gabe's mom, Katie Rodriguez.

Скрыть анонс
14:52 Yahoo ScienceRoche says test showed Tecentriq helped vs bladder cancer

Roche Holding said its Tecentriq drug combined with platinum-based chemotherapy reduced the risk of the disease worsening or death in patients with advanced bladder cancer, the Swiss pharma company said on Monday. Tecentriq was the first cancer immunotherapy approved in bladder cancer, with Roche now evaluating the treatment in combination with other medicines for early and advanced forms of the disease. The Phase III study met its targets of preventing the condition worsening, when compared with chemotherapy alone.

Скрыть анонс
14:50 Reuters.com HealthRoche says test showed Tecentriq helped vs bladder cancer

Roche Holding said its Tecentriq drug combined with platinum-based chemotherapy reduced the risk of the disease worsening or death in patients with advanced bladder cancer, the Swiss pharma company said on Monday.

Скрыть анонс
14:41 SeekingAlpha.comRoche's Tecentriq shows positive effect in newly diagnosed patients with advanced bladder cancer

Скрыть анонс
13:09 Yahoo ScienceAustralia cancer sufferer first to use new assisted dying law

A 61-year-old cancer patient has become the first person in over two decades to die under controversial assisted dying laws in Australia, a charity said. Kerry Robertson died in July, three months after the mother-of-two ceased treatment for metastatic breast cancer, the support group Go Gentle Australia said Sunday.

Скрыть анонс
12:06 NYT HealthCancer Treatment at the End of Life

Too often, people with incurable cancers pursue therapy beyond any hope of benefit — except, perhaps, to the pockets of Big Pharma.

Скрыть анонс
10:47 FinancialExpress.comEuthanasia: Australia’s cancer sufferer first to use new assisted dying law

Robertson, who ended her life in the southeastern town of Bendigo, was diagnosed with breast cancer in 2010 -- which then spread into her bones, lung, brain, and liver.

Скрыть анонс
09:49 Technology.orgLiver Damage More Commonly Due to Malignant Tumors than Cancer Immunotherapy Drug

Immunotherapy as a treatment for advanced solid organ tumors has rapidly evolved over the past decade, often yielding

Скрыть анонс
05:36 Yahoo ScienceWhy It Can Be So Hard to Have Sex After Cancer (and What to Do About It)

If you're having trouble restarting your sex life after cancer, you're not alone. Discover some reasons you may be struggling and how to overcome them.

Скрыть анонс
03:46 MedicalNewsToday.comMedical News Today: How a dietary change might boost cancer therapy

A study in mice finds that eating less of a particular amino acid that is found in high levels in meat and eggs enhances the effects of cancer treatments.

Скрыть анонс
02:18 BBC HealthBeauty vlogger Dawn Lee on why she's sharing her cancer journey

Dawn Lee is sharing her experience of chemotherapy online, attracting millions of views.

Скрыть анонс
01:19 Yahoo ScienceThis Woman Thought She Had A Pimple Under Her Eye—But It Turned Out To Be Skin Cancer

“I was going back and looking at old pictures. I had that spot for three years.”

Скрыть анонс
04.08.2019
22:22 Yahoo Science3 Lung Cancer Stocks That Could Soar in September

These industry giants could make big moves after this year's World Conference on Lung Cancer.

Скрыть анонс
22:22 Yahoo.com Business3 Lung Cancer Stocks That Could Soar in September

These industry giants could make big moves after this year's World Conference on Lung Cancer.

Скрыть анонс
22:05 ScientificAmerican.ComCancer Medicine Is Failing Us

Our aggressive, expensive approach to cancer is doing more harm than good -- Read more on ScientificAmerican.com

Скрыть анонс
16:42 Yahoo ScienceThis Woman Thought She Had A Pimple Under Her Eye—But It Turned Out To Be Skin Cancer

“I was going back and looking at old pictures. I had that spot for three years.”

Скрыть анонс
15:16 Yahoo ScienceThis Woman Thought She Had a Pimple Under Her Eye—But It Turned Out to Be Skin Cancer

“I was going back and looking at old pictures. I had that spot for three years.”

Скрыть анонс
03.08.2019
22:09 News-Medical.NetFight CRC publishes manuscript investigating colon and rectal cancer in young adults

Fight Colorectal Cancer, the nation's largest advocacy organization dedicated to colon and rectal cancers announced today that the manuscript, "A summary of the Fight Colorectal Cancer working meeting: Exploring risk factors and etiology of sporadic early-age onset colorectal cancer" has been published in the August 2019 edition of Gastroenterology.

Скрыть анонс
21:25 News-Medical.NetGW Cancer Center selected as first global clinical trial site for high risk cutaneous squamous cell carcinoma

Under the leadership of Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University Cancer Center, the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.

Скрыть анонс
03:35 MedicalNewsToday.comMedical News Today: Does vitamin A help reduce skin cancer risk?

A new study suggests that people who have a higher vitamin A intake may have a lower risk of developing a common form of skin cancer.

Скрыть анонс
01:05 Drugs.comFinances Affect Women's Choice of Breast Cancer Treatment: Study

FRIDAY, Aug. 2, 2019 -- Cost often influences breast cancer patients' decisions about surgery, even if they have good incomes and insurance, a new study finds. "Eligible women with early-stage breast cancer often have choices for surgical treatments...

Скрыть анонс
00:55 SeekingAlpha.comJ&J says jury rejects baby powder/cancer claim

Скрыть анонс
00:33 CancerNetwork.comCan Deep Learning Algorithms Speed Up Lung Cancer Care?

Researchers tried using deep machine learning to anticipate disease outcomes and progression in patients with lung cancer.

Скрыть анонс
00:00 Yahoo ScienceHow to Spot the Symptoms of Thyroid Cancer, the Fastest Growing Cancer in the U.S.

Women are three times more likely to develop the disease than men.

Скрыть анонс
02.08.2019
23:25 CancerNetwork.comQuiz: Metastatic Prostate Cancer

Test your knowledge of metastatic prostate cancer with this month's quiz.

Скрыть анонс
23:19 Nature.ComMatching tumours to treatment buys time for those with a deadly cancer

Скрыть анонс
22:14 SeekingAlpha.comFDA OK's Daiichi's pexidartinib for rare synovial cancer

© seekingalpha.com. Use of this feed is limited to personal, non-commercial use and is governed by Seeking Alpha's Terms of Use (https://seekingalpha.com/page/terms-of-use). Publishing this feed for public or commercial use and/or misrepresentation by a third party is prohibited.

Скрыть анонс
21:26 News-Medical.NetScientists use AI to recognize patterns in breast cancer

Scientists have used artificial intelligence to recognize patterns in breast cancer - and uncovered five new types of the disease each matched to different personalized treatments.

Скрыть анонс
20:47 ScienceDaily.comAI reveals new breast cancer types that respond differently to treatment

Scientists have used artificial intelligence to recognize patterns in breast cancer -- and uncovered five new types of the disease each matched to different personalized treatments.

Скрыть анонс
18:07 ScienceDaily.comThe curious tale of the cancer 'parasite' that sailed the seas

A contagious canine cancer that conquered the world by spreading between dogs during mating likely arose around 6,000 years ago in Asia and spread around the globe through maritime activities, scientists say.

Скрыть анонс
15:43 FierceBiotech.comRakuten Medical reels in another megaround to fund cancer R&D

Rakuten Medical has raised $100 million to advance its pipeline of photoimmunotherapy oncology prospects. The biotech hopes to use antibodies and light to destroy cancer cells while leaving healthy tissues unharmed. 

Скрыть анонс
15:09 Technology.orgFeverfew could hold a secret to treating an incurable cancer

Feverfew is a common flowering garden plant. It has small flowers and looks rather lovely, but it is

Скрыть анонс
13:25 News-Medical.NetDiscovery of distinct lung cancer pathways could help future patients

Known for its poor prognosis, lung adenocarcinoma is the most common type of lung cancer, responsible for about 4 of 10 diagnoses, according to the National Cancer Institute.

Скрыть анонс
12:52 Technology.orgNew ‘don’t eat me’ signal may provide basis for cancer therapies

Researchers at the Stanford University School of Medicine have discovered a new signal that cancers seem to use to evade

Скрыть анонс
12:41 News-Medical.NetHIV-infected elderly cancer patients have worse outcomes despite treatment

Elderly cancer patients who are HIV-positive, particularly those with prostate and breast cancers, have worse outcomes compared to cancer patients in the same age range who do not have HIV.

Скрыть анонс
12:09 FinancialExpress.comShocking! Delhi’s toxic pollution turns fatal; 28-year-old non-smoker woman diagnosed with stage-four Lung Cancer

For the city's deteriorating air quality, several factors are being responsible, including construction activities, vehicular pollution as well as meteorological factors.

Скрыть анонс
11:32 GizmagScientists pluck an anti-cancer compound from a common flower


Feverfew is a common flower easily recognizable either from a home garden or the shelf of the local health store. For hundreds of years it's been used as a traditional medicine for migraines and other pains, though its actual usefulness in that regard is questionable. But now, researchers from the University of Birmingham have engineered a compound from the leaves of this plant that might be a potent cancer killer.
.. Continue Reading Scientists pluck an anti-cancer compound from a common flower Category: Medical Tags: Cancer Health Leukemia Medication Plants University of Birmingham

Скрыть анонс
06:48 Yahoo.com BusinessTrump claims he ll end the AIDS epidemic, cure childhood cancer at Cincinnati rally

Two promises resonated with people after President Donald Trump's rally in Cincinnati: curing pediatric cancer and ending AIDS.

Скрыть анонс
03:39 MedicalNewsToday.comMedical News Today: Cancer: These 4 genes help predict outcome

Using data from more than 10,000 people with cancer, research looks at mutations in the tumor protein p53 to better predict a person's outlook.

Скрыть анонс
03:39 MedicalNewsToday.comMedical News Today: Cancer and nutrition research: How best to move it forward

In the proceedings of a recent conference about the interplay between nutrition and cancer, specialists note that interdisciplinarity is the way forward.

Скрыть анонс
01:54 ScienceDaily.comHidden chemistry in flowers shown to kill cancer cells

Researchers have shown that it's possible to produce a compound with anti-cancer properties directly from feverfew -- a common flowering garden plant.

Скрыть анонс
01:54 ScienceDaily.comCancer without end? Discovery yields fresh insights

Scientists describe the evolutionary dynamics of a sexually transmitted cancer affecting dogs, which arose in a single ancient animal, living as much as 8.5 millennia ago. The findings provide fresh insights into disease evolution relevant to human cancer study and treatment.

Скрыть анонс
01:33 Nature.ComPublisher Correction: Intercellular interaction dictates cancer cell ferroptosis via NF2–YAP signalling

Nature is the international weekly journal of science: a magazine style journal that publishes full-length research papers in all disciplines of science, as well as News and Views, reviews, news, features, commentaries, web focuses and more, covering all branches of science and how science impacts upon all aspects of society and life.

Скрыть анонс
01.08.2019
23:35 CancerNetwork.comThe Growing Link Between Cancer and Alzheimer’s Disease

People with cancer had a slower rate of memory decline both before and after diagnosis, compared with people who were cancer-free, according to the results of a population-based cohort study recently reported in JAMA Network Open. Previous research has shown an inverse association between developing cancer and Alzheimer’s disease, and this study provides further support for this relationship.

Скрыть анонс
23:35 CancerNetwork.comThe Growing Link Between Cancer and Alzheimer’s Disease

People with cancer had a slower rate of memory decline both before and after diagnosis, compared with people who were cancer-free, according to the results of a population-based cohort study recently reported in JAMA Network Open. Previous research has shown an inverse association between developing cancer and Alzheimer’s disease, and this study provides further support for this relationship.

Скрыть анонс
21:36 Medscape.ComBevacizumab Benefit in Large-Volume Ovarian Cancer

Although there was no benefit in overall survival in the primary treatment of ovarian cancer with maintenance bevacizumab, some hope remains for patients with large-volume disease.

Скрыть анонс
21:32 ScienceDaily.comResearchers unlock cancer cells' feeding mechanism, central to tumor growth

An international team led by researchers has discovered the energy production mechanism of cancerous cells that drives the growth of the nucleolus and causes tumors to rapidly multiply. The findings could lead to the development of new cancer treatments that would stop tumor growth by cutting the energy supply to the nucleolus.

Скрыть анонс
21:03 Phys.orgThe curious tale of the cancer 'parasite' that sailed the seas

A contagious canine cancer that conquered the world by spreading between dogs during mating likely arose around 6,000 years ago in Asia and spread around the globe through maritime activities, scientists say.

Скрыть анонс
20:58 ScienceDaily.comPrecision editing of gut bacteria reduces cancer in mice

Researchers have shown that precision editing of the bacterial populations in the gut reduces inflammation-associated colorectal cancer in mice.

Скрыть анонс
20:37 BBC HealthBrexit: Warning over cancer treatment supplies after no deal

In a letter to the prime minister, senior doctors express concerns over the supply of radioisotopes.

Скрыть анонс
19:57 ScienceDaily.comDiscovery of distinct lung cancer pathways may lead to more targeted treatments

Known for its poor prognosis, lung adenocarcinoma is the most common type of lung cancer, responsible for about 4 of 10 diagnoses. Researchers can now distinguish between two pathways where this deadly cancer can develop. They say their discovery could help future patients.

Скрыть анонс
18:57 Benzinga.comTracon Pharma Shares Rally As First Patient Dosed In Cancer Trial

Shares of the thinly traded nanocap biotech TRACON Pharmaceuticals Inc (NASDAQ: TCON) were rallying Thursday.
read more

Скрыть анонс
17:46 StemCellsPortal.comlNew clinical trial approved for breast cancer-related brain metastases

OAKLAND, CA (US), July 2019 – A new clinical trial under way that is testing a therapy to treat brain metastases from breast cancers expressing high levels of a protein called HER2.  Brain metastases are tumors in the brain that have spread from the original site of the breast cancer — the second-most common cancer in women, both in the United States and worldwide. 
Some types of breast cancer have a high likelihood of metastasizing to the brain.  When that happens, there are few treatment options, leading to a poor prognosis and poor quality of life. The clinical trial, funded by a $9.28 million grant from the California Institute for Regenerative Medicine (CIRM), is being conducted by Saul Priceman, Ph.D., in City of Hope’s Department of Hematology & Hematopoietic Cell Transplantation. The therapy consists of a genetically modified version of the patient’s own T

Скрыть анонс
16:06 ScientificAmerican.ComDarwin's Ideas on Evolution Drive a Radical New Approach to Cancer Drug Use

Principles of evolution and natural selection drive a radical new approach to drugs and prevention strategies -- Read more on ScientificAmerican.com

Скрыть анонс
14:29 Benzinga.comThe Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 1)
read more

Скрыть анонс
11:39 News-Medical.NetDiscovery of protective protein could open door to better treatment of fast-growing cancer cells

The discovery that an essential protein plays a protective role during cell division, could open the door to better targeted treatment of fast-growing cancer cells.

Скрыть анонс
11:30 ClinicalOncology.comKeytruda Monotherapy Granted Esophageal Cancer Indication

The FDA approved pembrolizumab (Keytruda, Merck) monotherapy for patients with recurrent locally advanced or metastatic PD-L1  positive esophageal squamous cell carcinoma whose disease progresses after one or more prior lines of systemic therapy. 

Скрыть анонс
09:52 News-Medical.NetPsychological stress linked to higher risk of cancer-specific mortality in cervical cancer patients

Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Скрыть анонс
09:40 News-Medical.NetPreliminary study for detection of pancreatic cancer shows encouraging results

OTraces, Inc., a molecular diagnostics company specializing in early cancer detection, has announced completion of a preliminary study for detection of pancreatic cancer.

Скрыть анонс
08:07 News-Medical.NetSkin cancer risk falls with higher dietary vitamin A intake

A new study from Brown University shows that the dietary intake of vitamin A from plant sources is associated with a lower risk of a common type of skin cancer called squamous cell carcinoma. This is the second most common carcinoma of the skin in fair-skinned people.

Скрыть анонс
06:36 Yahoo.com BusinessCan diet help cancer treatment? Study in mice offers clues

Diet is already a key part of managing diseases like diabetes and hypertension, but new research adds to a growing body of evidence that it could help cancer treatment too. The study, published Thursday in the journal Nature, found restricting intake of an amino acid found in red meat and eggs significantly enhanced cancer treatment in mice, slowing tumour growth. "These are very strong effects, and they are effects that are as strong as we would see with drugs that work," said lead researcher Jason Locasale, an associate professor at Duke University's School of Medicine.

Скрыть анонс
06:24 Yahoo ScienceCan diet help cancer treatment? Study in mice offers clues

Diet is already a key part of managing diseases like diabetes and hypertension, but new research adds to a growing body of evidence that it could help cancer treatment too. The study, published Thursday in the journal Nature, found restricting intake of an amino acid found in red meat and eggs significantly enhanced cancer treatment in mice, slowing tumour growth. "These are very strong effects, and they are effects that are as strong as we would see with drugs that work," said lead researcher Jason Locasale, an associate professor at Duke University's School of Medicine.

Скрыть анонс
06:09 News-Medical.NetGenetically tweaking gut bacteria reduces risk of colorectal cancer in mice finds study

Researchers have found that editing of the genes of the bacteria present in the guts of mice could help reduce the inflammation and associated risk of colorectal cancers.

Скрыть анонс
03:39 Yahoo ScienceThis new lung cancer screening tool is designed to catch the disease early on

A new test called a low-dose CT scan is designed to catch lung cancer early, when it’s more likely to be curable.

Скрыть анонс
03:39 Yahoo Science Nobody deserves cancer : There s a lung cancer stigma, and it s making people sick

Learning you have cancer is a difficult diagnosis to bear. But for people with lung cancer, there’s an added layer of stress thanks to a pervasive and harmful stigma associated with the disease.

Скрыть анонс
02:32 Technology.orgDeeper understanding of nanobubbles could improve the design of ships’ propellers and cancer treatment

Ship propellers are like wheels on a car. They do experience a lot of stress and wear rather

Скрыть анонс
02:05 ScienceDaily.comLiquid biopsy chip snares circulating tumor cells in blood drops from cancer patients

Researchers have developed a chip made of carbon nanotubes that can capture circulating tumor cells (CTCs) of all sizes and types, and can do so with far greater sensitivity than existing technologies. The unique design of the device makes it possible to easily identify and even culture the captured cells, which could make it possible to detect early-stage tumors, predict the course of a cancer, and monitor the effects of therapy.

Скрыть анонс
02:05 ScienceDaily.comHigher vitamin A intake linked to lower skin cancer risk

Researchers found that people who ate high levels of vitamin A were 17 percent less likely to get the second-most-common type of skin cancer years later.

Скрыть анонс
01:54 ScienceDaily.comProtective protein guards against DNA damage and could help target fast growing cancer cells

The discovery that an essential protein plays a protective role during cell division, could open the door to better targeted treatment of fast-growing cancer cells.

Скрыть анонс
00:53 VentureBeat.comAI takes advantage of existing mammography scans to make a cancer diagnosis

In a preprint paper, researchers propose an AI model that takes advantage of prior mammography scans in making a cancer diagnosis

Скрыть анонс
00:39 NYT ScienceColorectal Cancer Rises Among Younger Adults

These cancers are much more common in older patients. But new data show a sharp increase among adults in their 20s and 30s.

Скрыть анонс
00:31 Yahoo ScienceFor 6 Years, Doctors Kept Telling Me I Had PMS—but It Turned Out to Be Brain Cancer

Karissa Ostheimer, 34, regularly experienced brief yet terrifying episodes that left her frozen and unable to speak. But only when she had one behind the wheel and crashed her car did doctors consider they could be related to something far more serious than her period.

Скрыть анонс
00:27 NYT HealthColorectal Cancer Rises Among Younger Adults

These cancers are much more common in older patients. But new data show a sharp increase among adults in their 20s and 30s.

Скрыть анонс
31.07.2019
22:45 News-Medical.NetPromising antibody therapy reduces tumor growth, increases survival in mice with pancreatic cancer

Scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion.

Скрыть анонс
22:39 ScienceDaily.comNew 'don't eat me' signal may provide basis for cancer therapies

Researchers have discovered a new signal that cancers seem to use to evade detection and destruction by the immune system. The scientists have shown that blocking this signal in mice implanted with human cancers allows immune cells to attack the cancers.

Скрыть анонс
22:12 Yahoo ScienceCan diet help cancer treatment? Study in mice offers clues

Diet is already a key part of managing diseases like diabetes and hypertension, but new research adds to a growing body of evidence that it could help cancer treatment too. The study, published Thursday in the journal Nature, found restricting intake of an amino acid found in red meat and eggs significantly enhanced cancer treatment in mice, slowing tumour growth. "These are very strong effects, and they are effects that are as strong as we would see with drugs that work," said lead researcher Jason Locasale, an associate professor at Duke University's School of Medicine.

Скрыть анонс
22:01 Yahoo.com BusinessAmgen Gains as Cancer Drug ‘Steals the Show’ From Legacy Woe

(Bloomberg) -- Shares of Amgen Inc. rose as much as 5.2% on Wednesday after early results from an experimental therapy showed promise in colon cancer and drew attention away from earnings and fears about the company’s aging portfolio.“AMG510 steals the show,” RBC analyst Kennen MacKay wrote in a note to clients while still cautioning investors on the company’s base business. Amgen plans to start a registrational study of the cancer medicine this year.“The New Amgen -- flat revenue, promising pipeline, nervous investors,” SVB Leerink analyst Geoffrey Porges quipped. Shares are on track to close with biggest gain since December 2018.RBC, Kennen MacKaySecond-quarter beat and raise “are likely to be overshadowed by the base business (especially Enbrel) driving the beat.”“Several bright spots do emerge,” MacKay wrote,

Скрыть анонс
21:03 Drugs.comVitamin A Linked to Lower Odds of Common Skin Cancer

WEDNESDAY, July 31, 2019 -- Wondering if you can do more than slap on some sunscreen to prevent skin cancer? A new study suggests that getting more vitamin A may help. The study of around 125,000 Americans found that people with the highest intake...

Скрыть анонс
21:00 News-Medical.NetHigh levels of vitamin A linked to reduced skin cancer risk

People whose diets included high levels of vitamin A had a 17 percent reduction in risk for getting the second-most-common type of skin cancer, as compared to those who ate modest amounts of foods and supplements rich in vitamin A.

Скрыть анонс
20:36 Medscape.ComDon't Stop Using DRE With Prostate Cancer Patients

The low-tech, low-cost digital rectal exam still has value — as a prognostic tool in men with prostate cancer.

Скрыть анонс
20:21 Nature.ComCD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy

Скрыть анонс
20:21 Nature.ComDietary methionine influences therapy in mouse cancer models and alters human metabolism

Скрыть анонс
20:21 Nature.ComLoss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis

Скрыть анонс
19:48 Medscape.ComFirst Approval for Immunotherapy for Esophageal Cancer

Esophageal cancer has now joined the list of tumor types that can be treated with a checkpoint inhibitor — in this case, with pembrolizumab (Keytruda).

Скрыть анонс
19:25 Medscape.ComAn Oncologist With Cancer: Mark Lewis Shares Unique Viewpoint

As an oncologist with pancreatic cancer, Mark Lewis brings a unique, valuable perspective to cancer care. He hopes you'll agree.

Скрыть анонс
17:48 SeekingAlpha.comNovartis' Kisqali extends survival in second late-stage breast cancer study

Скрыть анонс
17:23 News-Medical.NetDietary vitamin A may protect against common skin cancer

Increasing the intake of dietary vitamin A may reduce the risk of developing cutaneous squamous cell carcinoma (SCC), according to a new study.

Скрыть анонс
16:51 SeekingAlpha.comTCR2 Therapeutics teams up with NCI in cancer study of proprietary T cells

Скрыть анонс
16:14 Technology.orgUSask medical team receives $987,000 to test new imaging agents for improved cancer diagnosis

A University of Saskatchewan medical research team will receive $987,000 from Western Economic Diversification (WD) towards a $4.55-million

Скрыть анонс